Chronic Kidney Disease News

Measuring baseline and post-acute kidney function is key in evaluating the risk of adverse outcomes in patients requiring dialysis, according to a nationwide cohort study.

Non-alcoholic fatty liver disease is an independent risk factor for osteoarthritis, according to data published in Arthritis Research & Therapy.

Adults with obesity and end-stage renal disease may qualify as kidney transplant candidates, according to a joint study between a bariatric and transplant surgery team.

Adults with kidney failure at risk for diabetes-related foot ulcers who receive foot and ankle care may have a lower chance of diabetes-related amputation and death, according to recently published data.

I reflect on my privilege frequently. I live in a safe home in a leafy neighborhood with my wife and two children. We have employer-funded benefits. Our family is generally equipped to meet life’s challenges.

Balboa Nephrology and IKONA Health have entered into a partnership to develop, test and commercialize education for people with kidney disease, according to a press release.

Black veterans with new-onset chronic kidney disease had a 2.5-fold higher cumulative incidence of kidney failure compared with white veterans, according to a published study.

The FDA has granted a 7-year orphan drug exclusivity period for Tarpeyo, a medication for the treatment of primary immunoglobulin A nephropathy, according to a press release.

Compared with illnesses like cancer, heart failure and dementia, patients with end-stage kidney disease alone have among the lowest rates of survival after 5 years, Stanford University researchers reported in a published study.

Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.